(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5...
(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5-oxo-tetrahydrofuran-2-yl]butanoyl]-4-benzyl-oxazolidin-2-one
CAS: 173154-01-3
Molecular Formula: C24H32N4O5
(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5... - Names and Identifiers
(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5... - Physico-chemical Properties
| Molecular Formula | C24H32N4O5 |
| Molar Mass | 457 |
| Melting Point | 105℃ |
(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5... - Introduction
Compound (4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-] butanoyl]-4-benzyl-oxazolidin-2-one is an organic compound. The following is information about its nature, use, formulation and safety:
Nature:
-Appearance: Solid, may be crystalline or crystalline powder
-Molecular formula: c₂, H, NNO, O, and
-Molecular weight: 489.63g/mol
-Solubility: Soluble in organic solvents such as dichloromethane and dimethyl sulfoxide
Use:
-As a pharmaceutical intermediate: The compound can be used to synthesize potential biologically active compounds, such as ligands in pharmaceutical and biochemical research.
Method:
-The preparation of this compound is an organic synthesis process that usually requires chemical laboratory conditions and expertise. The specific preparation method may vary depending on the application and generally involves a multi-step reaction sequence.
Safety Information:
-Safety and toxicity data for compounds may be reported in the literature, but specific information may be limited. The use and handling of chemicals should follow laboratory and safety practices. Use of this compound should be carried out with appropriate training and specialized equipment, and in accordance with relevant regulations and laboratory safety guidelines.
Nature:
-Appearance: Solid, may be crystalline or crystalline powder
-Molecular formula: c₂, H, NNO, O, and
-Molecular weight: 489.63g/mol
-Solubility: Soluble in organic solvents such as dichloromethane and dimethyl sulfoxide
Use:
-As a pharmaceutical intermediate: The compound can be used to synthesize potential biologically active compounds, such as ligands in pharmaceutical and biochemical research.
Method:
-The preparation of this compound is an organic synthesis process that usually requires chemical laboratory conditions and expertise. The specific preparation method may vary depending on the application and generally involves a multi-step reaction sequence.
Safety Information:
-Safety and toxicity data for compounds may be reported in the literature, but specific information may be limited. The use and handling of chemicals should follow laboratory and safety practices. Use of this compound should be carried out with appropriate training and specialized equipment, and in accordance with relevant regulations and laboratory safety guidelines.
Last Update：2024-04-09 19:05:47
Supplier List
View History
(4S)-3-[(2S,4S)-4-azido-2-isopropyl-4-[(2S,4S)-4-isopropyl-5...
Phosphonic dichloride, (2-chloro-2-propenyl)- (9CI)
4,6-二溴噻吩并[3,4-B]噻吩-2-羧酸
ethyl 3-[6-chloro-4-methyl-7-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]-2-oxochromen-3-yl]propanoate
4-溴-3-硝基苯甲酸
四(乙睛)四氟硼酸钯
Cobalt(II) stearate
Dabigatran Impurity 4 (DABRC-04)
methyl 3-[(2-chloro-5-methylphenoxy)methyl]benzoate
3-(4-ACETOXY-PHENYL)-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID
Phosphonic dichloride, (2-chloro-2-propenyl)- (9CI)
4,6-二溴噻吩并[3,4-B]噻吩-2-羧酸
ethyl 3-[6-chloro-4-methyl-7-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethoxy]-2-oxochromen-3-yl]propanoate
4-溴-3-硝基苯甲酸
四(乙睛)四氟硼酸钯
Cobalt(II) stearate
Dabigatran Impurity 4 (DABRC-04)
methyl 3-[(2-chloro-5-methylphenoxy)methyl]benzoate
3-(4-ACETOXY-PHENYL)-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID